01 1Viatris
01 1ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-06
Pay. Date : 2017-01-20
DMF Number : 31324
Submission : 2017-01-31
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USP, with a corresponding US DMF Number 31324.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 06, 2017, and payment made on January 20, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
